Tak-Wah Mak

Tak-Wah Mak

Founder chez Tio Bioventures

77 ans
Health Technology
Consumer Services
Commercial Services

Profil

Tak-Wah Mak is the founder of Agios Pharmaceuticals, Inc. (2007) and Treadwell Therapeutics, Inc. (2019).
He is currently the Director & Chief Scientific Officer at Miikana Therapeutics, Inc. (since 2002), Director at The Campbell Family Institute for Breast Cancer Research, Professor at the University of Toronto (since 1984), Associate at National Academy of Sciences, and Associate at American Academy of Arts & Sciences.
His former positions include Director at CASI Pharmaceuticals, Inc. (2012-2016) and Director at Hong Kong Science & Technology Parks Corp.
Dr. Mak holds a doctorate from the University of Alberta and undergraduate and graduate degrees from the University of Wisconsin.
Dr. Mak is also the founder of Tio Bioventures.

Postes actifs de Tak-Wah Mak

SociétésPosteDébut
Chief Tech/Sci/R&D Officer 01/01/2002
University of Toronto Corporate Officer/Principal 01/01/2003
The Campbell Family Institute for Breast Cancer Research Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Founder -
Tous les postes actifs de Tak-Wah Mak

Anciens postes connus de Tak-Wah Mak

SociétésPosteFin
Director/Board Member 02/06/2016
Founder -
Director/Board Member -
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
Voir l'expérience en détail de Tak-Wah Mak

Formation de Tak-Wah Mak

University of Alberta Doctorate Degree
University of Wisconsin Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Tak-Wah Mak

Relations

100 +

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
AGIOS PHARMACEUTICALS, INC.

Health Technology

Entreprise privées8

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

The Campbell Family Institute for Breast Cancer Research

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Tak-Wah Mak